Skip to main content

Find Clinical Trials

Home
Conditions
Human African Trypanosomiasis (HAT)

Clinical trial condition

Human African Trypanosomiasis (HAT)

Explore clinical trials studying Human African Trypanosomiasis (HAT). Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Human African Trypanosomiasis (HAT) trial results

Completed

Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study

NCT02184689

Conditions: Human African Trypanosomiasis (HAT)
Locations: Kinshasa, Democratic Republic of the Congo

View Trial Details

Completed

Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study

NCT02169557

Conditions: Human African Trypanosomiasis (HAT)
Locations: Kinshasa, Democratic Republic of the Congo

View Trial Details

Completed

Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2

NCT01685827

Conditions: Euglenozoa Infections, Human African Trypanosomiasis (HAT), Infections, +6 more
Locations: Batangafo Batangafo, Central African Republic

Bagata Hospital Bagata, Bandundu, Democratic Republic of the Congo

Masi Manimba Hospital Masi Manimba, Bandundu - DRC, Republic of the Congo

Vanga Hospital Vanga, Bandundu - DRC, Republic of the Congo

View Trial Details